Mustang Bio Inc (MBIO)
0.2684
0.00 (0.00%)
USD |
NASDAQ |
May 10, 15:32
Mustang Bio Enterprise Value: -3.427M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | -3.427M |
| May 08, 2024 | -3.261M |
| May 07, 2024 | -3.283M |
| May 06, 2024 | -3.107M |
| May 03, 2024 | -2.932M |
| May 02, 2024 | -3.190M |
| May 01, 2024 | -3.532M |
| April 30, 2024 | -3.657M |
| April 29, 2024 | -3.772M |
| April 26, 2024 | -2.950M |
| April 25, 2024 | -2.593M |
| April 24, 2024 | -2.596M |
| April 23, 2024 | -2.497M |
| April 22, 2024 | -2.701M |
| April 19, 2024 | -2.685M |
| April 18, 2024 | -2.379M |
| April 17, 2024 | -2.244M |
| April 16, 2024 | -2.637M |
| April 15, 2024 | -2.338M |
| April 12, 2024 | -0.9558M |
| April 11, 2024 | -0.5485M |
| April 10, 2024 | -0.8353M |
| April 09, 2024 | 0.7897M |
| April 08, 2024 | 1.024M |
| April 05, 2024 | 1.690M |
| Date | Value |
|---|---|
| April 04, 2024 | 1.922M |
| April 03, 2024 | 2.286M |
| April 02, 2024 | 4.364M |
| April 01, 2024 | 4.676M |
| March 28, 2024 | 4.572M |
| March 27, 2024 | 3.533M |
| March 26, 2024 | 3.439M |
| March 25, 2024 | 3.740M |
| March 22, 2024 | 4.987M |
| March 21, 2024 | 5.403M |
| March 20, 2024 | 5.611M |
| March 19, 2024 | 4.624M |
| March 18, 2024 | 4.572M |
| March 15, 2024 | 3.637M |
| March 14, 2024 | 4.101M |
| March 13, 2024 | 3.833M |
| March 12, 2024 | 4.780M |
| March 11, 2024 | 5.818M |
| March 08, 2024 | 6.754M |
| March 07, 2024 | 6.582M |
| March 06, 2024 | 5.937M |
| March 05, 2024 | 6.213M |
| March 04, 2024 | 6.213M |
| March 01, 2024 | 6.029M |
| February 29, 2024 | 6.213M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-40.66M
Minimum
Mar 14 2022
272.51M
Maximum
Jan 22 2021
59.46M
Average
53.13M
Median
Mar 20 2020
Enterprise Value Benchmarks
| Fortress Biotech Inc | -4.942M |
| Avinger Inc | 15.58M |
| AIM ImmunoTech Inc | 9.406M |
| Protalix BioTherapeutics Inc | 67.01M |
| Armata Pharmaceuticals Inc | 186.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.616M |
| Total Expenses (Quarterly) | 8.856M |
| EPS Diluted (Quarterly) | -0.71 |
| Earnings Yield | -2.24K% |